Sep 2026· European Journal of Clinical Nutrition· 0 citations· 9 references
Medicine
TL;DR
The potential of the ketogenic diet as a unified therapeutic approach to improve clinical outcomes in patients with co-existing NKH and biotinidase deficiency is highlighted, highlighting the potential of the KD as a unified therapeutic approach to improve clinical outcomes in patients with co-existing NKH and biotinidase deficiency.
BACKGROUND
Glucose transporter type 1 deficiency syndrome (GLUT1-DS) is a rare, paediatric onset, neurometabolic disorder caused by impaired cerebral glucose transport, leading to chronic brain energy deficiency. The classic ketogenic diet (CKD) is its established cornerstone therapy but it is not universally effective...
R. Falsaperla, Salma Ben Amer, Vincenzo Sortino· Epilepsy Research· 0 citations
Abstract Objectives Rabson–Mendenhall syndrome (RMS) is a rare monogenic insulin resistance disorder characterized by progressive dysglycemia and early mortality. Management of diabetic ketoacidosis (DKA) in RMS is particularly challenging because standard insulin doses may be inadequate, and pediatric-specific experie...
J. M. Azarudeen, R. Narayanan, Anjana Kar et al.· Journal of Pediatric Endocri...· 1 citation
HMGCS2 deficiency, BKTD, and SCOT deficiency show overlapping features but can be distinguished by ketone levels, glucose patterns, and acylcarnitine profiles.
Burcu Koseci, Ezgi Burgaç, Ahmet Yöntem et al.· Journal of Pediatric Endocri...· 0 citations
Miller–Dieker syndrome (MDS) is a rare genetic disorder characterized by classical lissencephaly, severe neurodevelopmental impairment, and early‐onset drug‐resistant epilepsy. Feeding difficulties and aspiration pneumonia significantly contribute to morbidity and mortality. Evidence regarding ketogenic diet (KD) thera...
Perrone Michela, Porro Matteo, Piemontese Pasqua et al.· Case Reports in Pediatrics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.